| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|
Horizon 14 Male plus TSE Natera, Inc.
United States | 12 | 14 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 106 plus TSE Natera, Inc.
United States | 103 | 107 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 plus TSE Natera, Inc.
United States | 28 | 29 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Plus TSE Natera, Inc.
United States | 265 | 275 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 plus TSE Natera, Inc.
United States | 135 | 138 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 14 plus TSE Natera, Inc.
United States | 15 | 16 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
IMPORTANT NOTE: NIH does not independently verify information submitted to
the GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute
for medical advice. Patients and consumers with specific questions
about a genetic test should contact a health care provider or a genetics professional.
